Edesa Biotech EDSA
NASDAQ EDSA
$2.89 +0.04 (+1.40%)
As of: Oct 22, 2026 · 9:30 AM EDT

Edesa Biotech (EDSA) Finished Goods (2015)

Updated

Edesa Biotech (EDSA) posted Finished Goods of $377,710 for fiscal Q4 2015 (quarter ended Sep 30, 2015), up 249.5% from the prior quarter.

Analysis

Edesa Biotech (EDSA) Finished Goods (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn
10 Edesa Biotech 26.03 Mn -19.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 377,710.00
Jun 30, 2015 108,074.00
API Access

Edesa Biotech Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=EDSA&period=max&api_key=YOUR_API_KEY